MMEN — Medmen Enterprises Balance Sheet
0.000.00%
Consumer CyclicalsSpeculativeMicro Cap
Annual balance sheet for Medmen Enterprises, fiscal year end - June 25th, USD millions except per share, conversion factor applied.
R2018 June 30th | 2019 June 29th | R2020 June 27th | C2021 June 26th | R2022 June 25th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | Interim Report |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 79.2 | 33.8 | 13.4 | 14.6 | 11.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.83 | 9.87 | 14.2 | 8.96 | 8.52 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 111 | 116 | 72.7 | 176 | 160 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 88.7 | 221 | 266 | 169 | 104 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 294 | 635 | 574 | 472 | 321 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 83.8 | 115 | 183 | 347 | 314 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 186 | 399 | 414 | 281 | 161 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 109 | 236 | 160 | 192 | 160 |
| Total Liabilities & Shareholders' Equity | 294 | 635 | 574 | 472 | 321 |
| Total Common Shares Outstanding |